跳至主要内容
临床试验/NCT05452291
NCT05452291招募中不适用

Exploring Multiomics Biomarkers for Urolithiasis

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2022年5月27日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,200
试验地点
1
主要终点
Change of Level of urinary metabolomics by multiomics approach in non-stone former

研究概览

简要总结

This is a prospective case series study. To compare urine sample of recurrent stone-formers and non-stone former by multiomics approach to identify potential markers for stone recurrence.

详细描述

A total of 100 Chinese patients with history of recurrent urinary stone and no history of urinary stone disease (control) will be recruited for the study.

Urine will be saved for multiomics analysis, including metabolomics, proteomics, etc. Thereafter, integrated multiomics calculation of recurrent stone can be studied for the differentiation of recurrent stone former and non-stone former.

After completing the preliminary and screening experiments, a large validation cohort (1000 Chinese patients with history of recurrent urinary stone) will be carried out. The patients will then be follow-up in clinic for at least 3 years, with minimum annual review and imaging to detect for any stone recurrence, as defined as increase in stone size and number, or symptomatic stone events. Targeted biomarkers measurement, based on part 1 result, will be done and the result will be used to correlated with the clinical outcomes of stone recurrence.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with history of recurrent urinary stone
  • Age greater than or equal to 18 years old
  • Have more than 2 episodes of radio-opaque stone disease (bilateral stones were counted as two episode)
  • Patients with no history of urinary stone disease
  • Age greater than or equal to 18 years old
  • With no history of urinary calculi, from history and imaging.
  • Exclusion criteria:
  • Patient refused or unable to provide consent for the study
  • Patient with active urinary infection
  • Patient with radiolucent stone or infective stone
  • Patients with no history of urinary stone disease (for control group)
  • Patient refused or unable to provide consent for the study
  • Patient with active urinary infection

排除标准

  • 未提供

结局指标

主要结局

Change of Level of urinary metabolomics by multiomics approach in non-stone former

时间窗: every year up to 3 year

Patient will be reviewed with urine collection for the level of urinary metabolomics including metabolomics and proteomics by multiomics analysis every year up to 3 years

Change of Level of urinary proteomics by multiomics approach in recurrent stone-formers

时间窗: every year up to 3 year

Patient will be reviewed with urine collection for the level of urinary metabolomics including metabolomics and proteomics by multiomics analysis and there will be radiological imaging annually to check if there is any suspect stone every year up to 3 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chi Fai NG

Professor

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验